|
BUYINS.NET: DFR, WNR, AMSC, CBMX, HDSN, TRMS Have Been Added To Naked
Short List Today
(M2 PressWIRE Via Acquire Media NewsEdge)
RDATE:22052008
BUYINS.NET, www.buyins.net, announced today that these select companies
have been added to the NASDAQ, AMEX and NYSE naked short threshold
list: Deerfield Capital Corp. (NYSE: DFR), Western Refining Inc. (NYSE:
WNR), American Superconductor Corp. (NASDAQ: AMSC), CombiMatrix Corp.
(NASDAQ: CBMX), Hudson Technologies Inc. (NASDAQ: HDSN), Trimeris Inc.
(NASDAQ: TRMS). For a complete list of companies on the naked short
list please visit our web site. To find the SqueezeTrigger Price before
a short squeeze starts in any stock, go to www.buyins.net.
Deerfield Capital Corp. (NYSE: DFR) is a real estate investment trust.
The firm invests in real estate-related securities, commercial mortgage
backed securities, bank loans, leveraged finance securities and
alternative assets. It primarily provides junior debt including second
lien and mezzanine and one-stop debt financings, with a limited
appetite for preferred stock and non-control common equity investments.
The firm invests in growth, change of control transactions, strategic
acquisitions, and recapitalizations. It typically invests between $10
million to $40 million in companies with minimum annual EBITDA of $5
million with a focus on North America. The firm also invests in Western
Europe. For mortgage investing, it invests in Agency and AAA-rated
non-Agency loans with target duration of one year or less. For direct
real estate lending, it provides mezzanine financing, platform
investment, and institutional investment, For mezzanine investing, it
invests in property types including office, retail, multi-family,
industrial, hospitality, senior housing, and land of United States. For
platform investments, it provides capital to financial companies and
real estate sponsors on a platform basis through first loss financing
on warehouse lines; Equity Bridge lines with a transaction size between
$20 million and $90million with multiple assets as collateral. For
institutional investment, the firm invests in first and second lien
debt, B notes, and mezzanine offerings arranged by investment and
commercial banks to real estate related companies and project finance
secured by real estate. It was formerly known as Deerfield Triarc
Capital Corp. Deerfield Capital Corp was founded in 2004 and is based
in Rosemont, Illinois. With 51.66 million shares outstanding and 8.7
million shares declared short as of April 2008, there is a failure to
deliver in shares of DFR. According to quarterly data provided by the
SEC, there were still 29,359 shares of DFR that were failing-to-deliver
as of September 21, 2007.
Western Refining Inc. (NYSE: WNR) through its subsidiaries, operates as
an independent crude oil refiner and marketer of refined products. The
company operates through three groups: Refining Group, Wholesale Group,
and Retail Group. Its Refining Group operates four refineries and
related refined products terminals, and asphalt terminals. The
company's Refining Group refines crude oil and other feed stocks into
finished products, such as gasoline, diesel fuel, jet fuel, and
asphalt, as well as markets its products to wholesale distributors and
retail chains. Its Wholesale Group distributes commercial wholesale
petroleum products primarily in Arizona, California, Colorado, Nevada,
New Mexico, Texas, and Utah to customers in the mining, construction,
utility, manufacturing, transportation, aviation, and agricultural
industries. The company's Retail Group operates service stations, which
include convenience stores or kiosks that sell gasoline, diesel fuel,
general merchandise, and beverage and food products. As of February 22,
2008, the company owned and operated 155 retail service stations and
convenience stores in Arizona, Colorado, and New Mexico. Western
Refining, Inc. is headquartered in El Paso, Texas. With 68.03 million
shares outstanding and 6.93 million shares declared short as of April
2008, there is a failure to deliver in shares of WNR. According to
quarterly data provided by the SEC, there were still 38,802 shares of
WNR that were failing-to-deliver as of September 28, 2007.
American Superconductor Corp. (NASDAQ: AMSC) offers an array of
solutions based on two proprietary technologies, programmable power
electronic converters and high temperature superconductor (HTS) wires.
Its products, services, and system-level solutions enable generation,
delivery, and use of electric power. The company, operating in the
alternative energy sector, offers grid interconnection solutions, as
well as licensed wind energy designs and electrical systems. It has two
segments, AMSC Power Systems and AMSC Superconductors. The AMSC Power
Systems segment produces a range of products to increase electrical
grid capacity and reliability; supplies electrical systems used in wind
turbines; sells power electronic products that regulate wind farm
voltage to enable their interconnection to the power grid; licenses
proprietary wind energy system designs to manufacturers of such
systems; and provides consulting services to the wind industry. This
segment offers power electronics; grid reliability, power quality, and
interconnection systems; and wind energy systems and solutions for
transmission and distribution, wind power, and manufacturing
industries. The AMSC Superconductors segment focuses on the
manufacturing of HTS wire and coils; the design and development of HTS
products, such as power cables, fault current limiters, and motors; and
the management of large-scale HTS projects, such as HTS power cable
system design, manufacturing, and installation. It sells its HTS wire
to original equipment manufacturers that incorporate HTS wire into
value-added products for electric utilities, ship integrators, and
industrial end-users. The company was founded in 1987 and is
headquartered in Devens, Massachusetts. With 41.5 million shares
outstanding and 9.27 million shares declared short as of April 2008,
there is a failure to deliver in shares of AMSC. According to quarterly
data provided by the SEC, there were still 17,464 shares of AMSC that
were failing-to-deliver as of September 27, 2007.
CombiMatrix Corp. (NASDAQ: CBMX) together with its subsidiaries,
develops technologies, products, and services in the areas of drug
development, genetic analysis, molecular diagnostics, nanotechnology
research, defense, and homeland security. Its technologies include a
platform to produce customizable, in-situ synthesized, and
oligonucleotide arrays for use in identifying and determining the roles
of genes, gene mutations, and proteins in the areas of genomics,
proteomics, biosensors, drug discovery, drug development, diagnostics,
combinatorial chemistry, material sciences, and nanotechnology. The
company's products and services include CustomArray platform, an
oligonucleotide array for genetic studies; CatalogArray Microarrays for
gene expression studies, mutation analysis, and other studies;
Micro-RNA Arrays that are used to study micro-RNA molecules; DNA Array
Synthesizer, an instrument that enables researchers to fabricate DNA
arrays to their exact specifications; stripping reagents, which enables
researchers to re-use microarrays; ElectraSense Reader, an
electrochemical scanning instrument; and comparative genomic
hybridization arrays, which are used for research and molecular
diagnostic applications. CombiMatrix also offers proprietary molecular
synthesis and screening methods for the discovery of potential new
drugs. In addition, it develops capabilities of producing arrays that
utilize bacterial artificial chromosomes that enable genetic analysis;
and a series of compounds to address various oncology-related diseases.
CombiMatrix sells its products and services directly, with partners,
and through distributors to customers in the United States, Europe, and
Asia. The company was founded in 1995 and is based in Mukilteo,
Washington. With 6.01 million shares outstanding and 151,100 shares
declared short as of April 2008, there is a failure to deliver in
shares of CBMX.
Hudson Technologies Inc. (NASDAQ: HDSN) through its subsidiary, Hudson
Technologies Company, provides various refrigerant products and
services primarily to the commercial air conditioning, industrial
processing, and refrigeration systems primarily in the United States.
It offers RefrigerantSide services, including system decontamination to
remove moisture, oils, and other contaminants, as well as predictive
and diagnostic services; and refrigerant management services, which
include reclamation of refrigerants, laboratory testing, storage
services to individual customer requirements, and reusable cylinder
repair and hydrostatic testing services. Hudson Technologies also sells
reclaimed and virgin refrigerants to various customers in the air
conditioning and refrigeration industry. The company serves commercial,
industrial, and government customers, as well as refrigerant
wholesalers, distributors, contractors, and refrigeration equipment
manufacturers. Its industrial customers principally operate in
petrochemical, pharmaceutical, industrial power, manufacturing,
commercial facility, and property management and maritime industries.
Hudson Technologies has a strategic alliance with The Linde Group to
market its service offering outside the U.S. The company was founded in
1991 and is headquartered in Pearl River, New York. With 19.07 million
shares outstanding and 6,500 shares declared short as of April 2008,
there is a failure to deliver in shares of HDSN.
Trimeris Inc. (NASDAQ: TRMS) a biopharmaceutical company, engages in
the development and commercialization of therapeutic agents for the
treatment of viral disease in the United States and Canada. It provides
a class of antiviral drug treatments, known as fusion inhibitors.
Fusion inhibitors impair viral fusion, a process by which viruses
attach to, penetrate, and infect host cells. The company offers FUZEON,
a 36-amino acid synthetic peptide that binds to a key region of the
human immunodeficiency virus (HIV) surface protein called gp41. FUZEON
blocks HIV viral fusion by interfering with certain structural
rearrangements within gp41 that are required for HIV to fuse to and
enter a host cell. It has a development and license agreement with F.
Hoffmann-La Roche, Ltd. to develop and market T-20, marketed as FUZEON.
The company was founded in 1993 and is based in Morrisville, North
Carolina. With 22.27 million shares outstanding and 5.29 million shares
declared short as of April 2008, there is a failure to deliver in
shares of TRMS. According to quarterly data provided by the SEC, there
were still 468,792 shares of TRMS that were failing-to-deliver as of
September 28, 2007.
About BUYINS.NET
WWW.BUYINS.NET is a service designed to help bonafide shareholders of
publicly traded US companies fight naked short selling. Naked short
selling is the illegal act of short selling a stock when no affirmative
determination has been made to locate shares of the stock to
hypothecate in connection with the short sale. Buyins.net has built a
proprietary database that uses Threshold list feeds from NASDAQ, AMEX
and NYSE to generate detailed and useful information to combat the
naked short selling problem. For the first time, actual trade by trade
data is available to the public that shows the attempted size, actual
size, price and average value of short sales in stocks that have been
shorted and naked shorted. This information is valuable in determining
the precise point at which short sellers go out-of-the-money and start
losing on their short and naked short trades.
BUYINS.NET has built a massive database that collects, analyzes and
publishes a proprietary SqueezeTrigger for each stock that has been
shorted, www.buyins.net/squeezetrigger.pdf. The SqueezeTrigger database
of nearly 1,950,000,000 short sale transactions goes back to January 1,
2005, and calculates the exact price at which the Total Short Interest
is short in each stock. This data was never before available prior to
January 1, 2005, because the Self Regulatory Organizations (primary
exchanges) guarded it aggressively. After the SEC passed Regulation
SHO, exchanges were forced to allow data processors like Buyins.net to
access the data.
The SqueezeTrigger database collects individual short trade data on
over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on
nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows
by approximately 50,000,000 short sale transactions and provides
investors with the knowledge necessary to time when to buy and sell
stocks with outstanding short positions. By tracking the size and price
of each month's short transactions, BUYINS.NET provides institutions,
traders, analysts, journalists and individual investors the exact price
point where short sellers start losing money.
All material herein was prepared by BUYINS.NET, based upon information
believed to be reliable. The information contained herein is not
guaranteed by BUYINS.NET to be accurate, and should not be considered
to be all-inclusive. The companies that are discussed in this opinion
have not approved the statements made in this opinion. This opinion
contains forward-looking statements that involve risks and
uncertainties. This material is for informational purposes only and
should not be construed as an offer or solicitation of an offer to buy
or sell securities. BUYINS.NET is not a licensed broker, broker dealer,
market maker, investment banker, investment advisor, analyst or
underwriter. Please consult a broker before purchasing or selling any
securities viewed on or mentioned herein. BUYINS.NET may receive
compensation in cash or shares from independent third parties or from
the companies mentioned.
BUYINS.NET affiliates, officers, directors and employees may also have
bought or may buy the shares discussed in this opinion and may profit
in the event those shares rise in value. Market commentary provided by
Thomas Ronk.
BUYINS.NET will not advise as to when it decides to sell and does not
and will not offer any opinion as to when others should sell; each
investor must make that decision based on his or her judgment of the
market.
This release contains "forward-looking statements" within the meaning
of Section 27A of the Securities Act of 1933, as amended, and Section
21E the Securities Exchange Act of 1934, as amended and such
forward-looking statements are made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995.
"Forward-looking statements" describe future expectations, plans,
results, or strategies and are generally preceded by words such as
"may", "future", "plan" or "planned", "will" or "should", "expected,"
"anticipates", "draft", "eventually" or "projected". You are cautioned
that such statements are subject to a multitude of risks and
uncertainties that could cause future circumstances, events, or results
to differ materially from those projected in the forward-looking
statements, including the risks that actual results may differ
materially from those projected in the forward-looking statements as a
result of various factors, and other risks identified in a companies'
annual report on Form 10-K or 10-KSB and other filings made by such
company with the Securities and Exchange Commission.
You should consider these factors in evaluating the forward-looking
statements included herein, and not place undue reliance on such
statements. The forward-looking statements in this release are made as
of the date hereof and BUYINS.NET undertakes no obligation to update
such statements.
CONTACT: Thomas Ronk, CEO, BUYINS.NET
Tel: +1 800 715 9999
e-mail: Tom@buyins.net
WWW: http://www.buyins.net
((M2 Communications Ltd disclaims all liability for information
provided within M2 PressWIRE. Data supplied by named party/parties.
Further information on M2 PressWIRE can be obtained at
http://www.presswire.net on the world wide web. Inquiries to
info@m2.com)).
Copyright ? 2008 M2 Communications Ltd.
[ Back To TMCnet.com's Homepage ]
|
Find Solutions for Enterprises, SMBs & Service Providers at the INTERNET TELEPHONY Conference and EXPO West, September 16-18, 2008. Los Angeles, California.
